Trial Profile
Phase I/II randomised, double-blind, placebo-controlled trial of trabodenoson [INO 8875] in patients with primary open-angle glaucoma or ocular hypertension
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 08 Oct 2013
Price :
$35
*
At a glance
- Drugs Trabodenoson (Primary)
- Indications Ocular hypertension; Open-angle glaucoma
- Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
- Sponsors Inotek Pharmaceuticals
- 08 Oct 2013 New trial record